Join to View Full Profile
460 W 10th AveFl 5Columbus, OH 43210
Phone+1 614-293-3196
Fax+1 614-293-7526
Dr. Choe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2014 - 2017
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2011 - 2014
Indiana University School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2013 - Present
OH State Medical License 2017 - 2027
NY State Medical License 2014 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) Start of enrollment: 2022 Jun 16
Roles: Contact
- Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD Start of enrollment: 2022 Apr 19
Roles: Sponsor-Investigator, Principal Investigator, Contact
- High Dose Vitamin a in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant Start of enrollment: 2020 Feb 07
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- DHODH inhibition alters T cell metabolism limiting acute graft-versus-host disease while retaining graft-versus-leukemia response.Rathan Kumar, Kara M Braunreiter, Lotus Neidemire-Colley, Natalie Sell, Yandi Gao
Journal of Immunology. 2025-03-22 - Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.Elvira Umyarova, Charles Pei, William Pellegrino, Qiuhong Zhao, Nidhi Sharma
Journal of Hematology & Oncology. 2025-03-18 - Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation.Rohtesh S Mehta, Hannah Choe, Jennifer Saultz, Zimu Gong, Prashant Sharma
American Journal of Hematology. 2025-03-12
Abstracts/Posters
- The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host DiseaseHannah K. Choe, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Effect of Early Post Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell TransplantationHannah K. Choe, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Bromodomain and Extraterminal (BET) Domain Inhibition with PLX51107 and PLX2853 Improves Survival and Decreases Acute GVHD Severity in Murine Models61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- PRMT5 Is Upregulated in Activated T Cells and Is a Novel Therapeutic Target for Acute Gvhd2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Syndax Announces New Data from Secondary Analysis of the Pivotal AGAVE-201 Trial of Niktimvo™ (Axatilimab-Csfr) in Chronic Graft-Versus-Host Disease to Be Presented at 66th ASH Annual MeetingNovember 5th, 2024- Actinium Highlights Ability of Iomab-B to Overcome High-Risk TP53 Mutation Resulting in Significant Improvement in Overall Survival in Patients with Active Relapsed Refractory AML at the European Bone Marrow Transplant Annual MeetingApril 19th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
